Quantoom Biosciences
Univercells announced the acquisition of SynHelix in January 2022.
SynHelix is now part of Quantoom Biosciences, a Univercells company.
Visit Quantoom Biosciences

Ahmed Said

Synhelix   →  Ahmed Said

Ahmed Said

Chief Technological Officer and co-founder

Ahmed is a passionate biotechnology engineer. He is particularly resourceful in optimizing processes for minimal costs.

Previously, he worked at Sanofi within the Global Biotherapeutics department at Vitry-sur-Seine, France. He achieved a successful experience in the bioproduction of complex proteins, including antibodies. In 2016, he joined DNA Script, a world-leading and pioneer company of the next-generation DNA synthesis. As a research engineer, he was in charge of the improvement of the DNA synthesis cycle. His work contributed to the scale-up of the process from the bench to the automation.